Last 21 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 78.00 | 29.01 | 21.14 | 51.69 | 945.00 | 32.74 | 55.38 | — | 43.89 | 25.35 | 33.86 | 36.83 | 16.41 | 28.21 | 32.56 | — | 17.41 | 38.59 | 39.09 | 61.23 | 30.76 |
| — | -11.4% | -61.8% | — | +2052.9% | +29.1% | +63.5% | — | +167.5% | -10.2% | +4.0% | — | -5.8% | -26.9% | -16.7% | — | -43.4% | -31.2% | — | — | — | |
| P/S Ratio | 0.56 | 0.59 | 0.31 | 0.32 | 0.37 | 0.47 | 0.61 | 0.57 | 1.46 | 1.00 | 1.24 | 1.29 | 1.04 | 1.06 | 1.27 | 1.17 | 1.42 | 1.65 | 2.12 | 4.32 | 4.64 |
| — | +26.4% | -49.0% | -43.1% | -74.9% | -53.0% | -50.9% | -55.9% | +40.4% | -5.7% | -2.1% | +10.1% | -26.8% | -35.5% | -40.0% | -72.9% | -69.4% | -59.8% | — | — | — | |
| P/B Ratio | 3.17 | 3.86 | 2.08 | 2.20 | 2.53 | 2.29 | 2.93 | 2.94 | 5.51 | 4.07 | 4.44 | 4.43 | 2.35 | 2.53 | 2.96 | 2.47 | 3.25 | 3.38 | 4.19 | 6.60 | 7.92 |
| — | +68.7% | -28.8% | -25.1% | -54.1% | -43.7% | -34.1% | -33.7% | +134.3% | +60.5% | +49.9% | +79.6% | -27.7% | -25.0% | -29.3% | -62.6% | -58.9% | -35.9% | — | — | — | |
| P/FCF | 17.03 | 6.22 | 4.69 | — | 47.36 | 3.44 | 27.93 | — | 22.05 | 23.90 | 89.58 | 37.17 | 32.02 | 15.87 | — | 4.10 | — | 57.93 | 85.10 | — | 24.97 |
| — | +80.7% | -83.2% | — | +114.8% | -85.6% | -68.8% | — | -31.2% | +50.6% | — | +806.7% | — | -72.6% | — | — | — | +13.2% | — | — | — | |
| EV / EBITDA | 19.54 | 16.71 | 10.17 | 13.49 | 14.56 | 12.28 | 15.56 | 47.89 | 20.47 | 13.97 | 14.96 | 447.51 | 8.12 | 11.31 | 15.62 | 19.82 | 8.38 | 22.36 | 17.92 | 125.40 | 18.19 |
| — | +36.1% | -34.7% | -71.8% | -28.8% | -12.1% | +4.0% | -89.3% | +152.1% | +23.6% | -4.3% | +2157.8% | -3.1% | -49.4% | -12.8% | -84.2% | -53.9% | -22.2% | — | — | — | |
| EV / EBIT | 30.92 | 16.71 | 12.49 | 18.75 | 21.67 | 13.83 | 25.24 | 68.62 | 20.48 | 12.94 | 16.68 | 72.78 | 8.43 | 10.07 | 18.37 | 25.32 | 10.52 | 23.87 | 28.35 | — | — |
| — | +20.9% | -50.5% | -72.7% | +5.8% | +6.8% | +51.3% | -5.7% | +143.0% | +28.6% | -9.2% | +187.4% | -19.9% | -57.8% | -35.2% | — | — | +184.0% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 9.3% | 10.7% | 9.4% | 8.3% | 8.5% | 11.9% | 11.5% | 9.5% | 15.4% | 13.6% | 17.0% | 11.0% | 20.9% | 15.9% | 14.2% | 14.0% | 24.0% | 14.7% | 16.2% | 11.9% | 35.1% |
| — | -10.2% | -18.7% | -12.7% | -44.4% | -12.3% | -32.5% | -14.2% | -26.6% | -14.6% | +20.0% | -20.9% | -13.1% | +8.2% | -12.2% | +17.1% | -31.4% | -34.5% | — | — | — | |
| Operating Margin | 2.5% | 3.5% | 3.0% | 1.9% | 2.0% | 3.1% | 3.3% | 0.1% | 5.9% | 6.2% | 7.5% | -1.1% | 11.2% | 7.8% | 6.6% | 4.3% | 15.8% | 5.7% | 10.0% | 1.2% | 23.4% |
| — | +13.6% | -10.9% | +1688.5% | -66.2% | -49.8% | -55.5% | +109.9% | -47.1% | -20.3% | +12.4% | -125.6% | -29.0% | +36.1% | -33.4% | +271.1% | -32.5% | -52.3% | — | — | — | |
| Net Margin | 0.7% | 2.0% | 1.5% | 0.6% | 0.0% | 1.4% | 1.1% | -1.0% | 3.4% | 3.9% | 3.7% | 3.5% | 6.3% | 3.8% | 3.9% | -0.9% | 7.3% | 4.4% | 5.2% | 7.1% | 15.1% |
| — | +41.0% | +38.7% | +160.4% | -98.8% | -63.5% | -70.6% | -129.9% | -46.9% | +4.2% | -5.8% | +496.1% | -13.4% | -14.6% | -25.5% | -112.5% | -51.5% | -38.5% | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.2% | 3.4% | 2.5% | 1.1% | 0.1% | 1.8% | 1.3% | -1.4% | 3.3% | 4.1% | 3.4% | 2.4% | 3.7% | 2.3% | 2.3% | -0.5% | 4.3% | 2.3% | 2.6% | 2.6% | 6.4% |
| — | +88.0% | +96.0% | +179.2% | -97.9% | -56.6% | -62.3% | -156.5% | -11.2% | +81.6% | +48.7% | +614.8% | -14.4% | +0.3% | -12.5% | -117.7% | -32.4% | -2.4% | — | — | — | |
| ROA | 1.3% | 0.9% | 0.6% | 0.3% | 0.0% | 0.7% | 0.5% | -0.5% | 1.3% | 1.5% | 1.4% | 1.2% | 2.1% | 1.3% | 1.3% | -0.3% | 2.4% | 1.3% | 1.5% | 1.6% | 3.9% |
| — | +25.2% | +26.6% | +151.1% | -98.4% | -56.1% | -63.7% | -142.8% | -39.6% | +18.6% | +2.5% | +552.3% | -14.2% | +1.7% | -13.3% | -117.2% | -37.0% | -9.4% | — | — | — | |
| ROIC | 6.2% | 2.2% | 1.8% | 1.2% | 1.6% | 2.2% | 2.2% | 0.1% | 3.4% | 3.8% | 4.6% | -0.6% | 5.3% | 3.9% | 3.3% | 1.7% | 6.8% | 2.3% | 4.0% | 0.3% | 7.3% |
| — | -2.2% | -17.7% | +1325.5% | -53.2% | -41.1% | -52.0% | +114.2% | -36.9% | -0.8% | +40.5% | -133.1% | -21.3% | +68.7% | -19.4% | +415.1% | -6.7% | -17.3% | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.93 | 1.64 | 1.84 | 1.93 | 1.96 | 0.83 | 0.87 | 0.92 | 0.94 | 0.99 | 0.96 | 0.78 | 0.38 | 0.39 | 0.40 | 0.41 | 0.40 | 0.42 | 0.38 | 0.39 | 0.38 |
| — | +96.7% | +111.6% | +110.4% | +108.9% | -16.2% | -9.0% | +17.4% | +145.2% | +151.7% | +142.2% | +90.3% | -5.1% | -7.0% | +4.4% | +4.3% | +7.3% | +15.6% | — | — | — | |
| Debt / EBITDA | 8.68 | 22.67 | 24.21 | 30.98 | 31.24 | 16.43 | 16.45 | 53.34 | 13.33 | 12.68 | 12.31 | 311.06 | 5.43 | 7.36 | 8.58 | 13.78 | 4.07 | 11.31 | 6.59 | 30.18 | 3.46 |
| — | +38.0% | +47.1% | -41.9% | +134.3% | +29.6% | +33.7% | -82.9% | +145.5% | +72.1% | +43.5% | +2157.1% | +33.5% | -34.9% | +30.2% | -54.3% | +17.7% | +42.2% | — | — | — | |
| Current Ratio | 1.40 | 1.23 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 | 1.91 | 1.84 | 1.51 | 2.11 | 2.35 | 2.50 | 2.76 | 2.88 | 2.84 | 2.49 | 2.77 | 3.53 | 3.66 |
| — | -22.5% | -20.6% | -19.7% | -26.5% | -13.7% | +12.3% | -17.3% | -18.7% | -26.6% | -45.1% | -26.7% | -17.4% | +0.6% | -0.5% | -18.3% | -22.4% | -32.3% | — | — | — | |
| Quick Ratio | 1.40 | 1.23 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 | 1.91 | 1.84 | 1.51 | 2.11 | 2.35 | 2.50 | 2.76 | 2.88 | 2.84 | 2.49 | 2.77 | 3.53 | 3.66 |
| — | -22.5% | -20.6% | -19.7% | -26.5% | -13.7% | +12.3% | -17.3% | -18.7% | -26.6% | -45.1% | -26.7% | -17.4% | +0.6% | -0.5% | -18.3% | -22.4% | -32.3% | — | — | — | |
| Interest Coverage | 1.79 | 2.70 | 2.22 | 1.43 | 1.32 | 3.28 | 2.31 | 0.77 | 4.03 | 4.71 | 4.16 | 1.17 | 11.06 | 9.67 | 6.94 | 5.06 | 18.04 | 9.97 | 18.03 | -20.34 | -4.69 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 21 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ASTH stock.
Astrana Health, Inc.'s current P/E is 78.0x. The average P/E over the last 4 quarters is 261.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Astrana Health, Inc.'s current operating margin is 2.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Astrana Health, Inc.'s business trajectory between earnings reports.